stocksbrew
Market
Explore
Watchlist
Market
Explore
Watchlist
stocksbrew.

Analyse any US stock, then track the ones you care about.

Appearance

Product

  • Market today
  • Explore
  • Watchlist
  • Earnings
  • US stocks
  • AI agent access

Free tools

  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Use cases
  • Developer API

Company

  • About
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

stocksbrew — Verified on SubmitForBacklinksFeatured on ScrollLaunchLaunched on FazierStocksBrew - Featured on Startup FameFeatured on Wired Business
A
A stock logo

Agilent Technologies

Large Cap · Healthcare · Diagnostics & Research

$154.22+$5.78 (+3.89%)
A
A stock logo

Agilent Technologies

Large Cap · Healthcare · Diagnostics & Research

$154.22+$5.78 (+3.89%)

Stock analysis

$154.22+$5.78 (+3.89%)

Get the AI take on A

Track it to unlock the price chart, verdict and what could change it.

  • ✓Live price chart
  • ✓A clear accumulate, trim or avoid call

Free to track. No card required.

Stock Fundamentals & Key Indicators

52-week range
Low$108.35
High$160.27
Today $154.22
RSI (14)
73.4Overbought
03070100

Overall score

70/100

See the full financial picture

Open the five-year record, valuation checks and Wall Street view behind these scores.

  • ✓5 years of revenue, profit and cash flow
  • ✓Valuation and balance-sheet checks
  • ✓Business and geographic mix
  • ✓Analyst targets and recommendation trend

Free for 3 days, then $9/mo. Cancel anytime.

Analyst Rating and Sentiment

Analyst price targets

Lowest

$135

Current price

$154.22

Median target

$159

Highest

$185

LowHigh

Operating Record

Revenue

What's working

  • ROIC: Money put back into the business keeps coming back out as profit, a hallmark of a durable moat.
  • ROE: Shareholder capital is compounding at a rate worth paying attention to.

What to watch

  • Debt exceeds cash by $1.7B, increasing balance-sheet pressure, a warning sign.
  • Forward P/E: The price already assumes strong earnings growth that still has to show up.

What the market charges

Forward P/E

Needs attention · 12% above avg

23.51x

Price / sales

Reasonable · Priced reasonably against its revenue

5.80x

Price / FCF

Rich · Priced far above what its cash flow currently supports

38.59x

EV / EBITDA

Reasonable · Operating earnings make this price a stretch but plausible

21.68x

How efficiently it compounds

ROIC

Strong · Comfortably clears the bar for efficient capital use

17.7%

ROE

Favorable · 21.3% - strong capital efficiency

21.3%

Debt / equity

Favorable · 0.47 - strong leverage

0.50x

Current ratio

Strong · Comfortable room to cover bills due within a year

2.10x

Peer Comparison

CompanyMkt capP/ERev growthScore
A
A stock logo
AAgilent Technologies
$41.95B29.8+9.1%70
GM
GMED stock logo
GMEDGlobus Medical
$11.53B22.0+19.7%78
IN
INDV stock logo
INDVIndivior
$4.60B13.9+13.5%77
DX
DXCM stock logo
DXCMDexcom
$33.87B35.4+15.5%77
LL
LLY stock logo
LLYEli Lilly and Company
$1.11T40.1+49.6%76

What is moving A

News

3 stories · 7d · A
  • MD
    MDT stock logo
    A
    A stock logo
    23h ago · Agilent Technologies via Nasdaq

    MDT vs. A: Which Stock Should Value Investors Buy Now?

    Bullish
  • MD
    MDT stock logo
    A
    A stock logo
    23h ago · Agilent Technologies via Yahoo Finance

    MDT vs. A: Which Stock Should Value Investors Buy Now?

    Mixed
  • AC
    ACET stock logo
    A
    A stock logo
    1d ago · Agilent Technologies via Nasdaq

    Are Medical Stocks Lagging Adicet Bio (ACET) This Year?

    Bullish
All market news→